Literature DB >> 24310519

Clinical and prognostic value of stress echocardiography appropriateness criteria for evaluation of coronary artery disease in a tertiary referral centre.

Sanjeev Bhattacharyya1, Vasilis Kamperidis, Navtej Chahal, Benoy N Shah, Isabelle Roussin, Wei Li, Rajdeep Khattar, Roxy Senior.   

Abstract

OBJECTIVE: Appropriateness criteria for stress echocardiography (SE) have been published to reduce the rate of inappropriate testing. We sought to investigate the clinical impact and prognostic value of these criteria.
METHODS: 250 consecutive patients undergoing SE for evaluation of coronary artery disease were classified into appropriate, uncertain and inappropriate categories according to appropriateness criteria. A positive SE was defined as the development of new wall motion abnormalities or a biphasic response. The primary end point was the composite of myocardial infarction and death.
RESULTS: Of the 250 SE, 120 (48%) were dobutamine studies and 130 (52%) were exercise studies. 156 (62.4%), 71 (28.4%) and 23 (9.2%) were classified as appropriate, inappropriate and uncertain, respectively. A significantly greater proportion of studies classified as appropriate 71 (45.5%) demonstrated inducible ischaemia compared with inappropriate studies 9 (12.7%) or uncertain studies 4 (17.4%), p<0.0001. During a median follow-up of 12.4 months, events occurred in 18 (11.5%), 2 (2.8%) and 0 patients classified as appropriate, inappropriate and uncertain, respectively. Event-free survival was significantly reduced in patients with a SE demonstrating ischaemia compared with patients without inducible ischaemia, p<0.0001. Kaplan-Meier curves demonstrated reduced event-free survival in patients with whose studies were classified as appropriate compared to inappropriate (p=0.01) or uncertain (p=0.05).
CONCLUSIONS: Appropriateness criteria differentiate between patients at high risk of ischaemia, subsequent revascularisation/cardiac events (appropriate group) and those at low risk of events (inappropriate group). A large proportion of SE is currently performed in inappropriate patients. Implementation of the criteria in clinical practice would reduce unnecessary testing.

Entities:  

Keywords:  Coronary Artery Disease

Mesh:

Year:  2013        PMID: 24310519     DOI: 10.1136/heartjnl-2013-304949

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Appropriate use criteria implementation with modified Haller index for predicting stress echocardiographic results and outcome in a population of patients with suspected coronary artery disease.

Authors:  Andrea Sonaglioni; Elisabetta Rigamonti; Gian Luigi Nicolosi; Michele Lombardo
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-07       Impact factor: 2.357

2.  Downstream clinical consequences of stress cardiovascular magnetic resonance based on appropriate use criteria.

Authors:  Sloane McGraw; Omer Mirza; Michael A Bauml; Vibhav S Rangarajan; Afshin Farzaneh-Far
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-15       Impact factor: 5.364

Review 3.  Appropriate Use of Cardiac Stress Testing with Imaging: A Systematic Review and Meta-Analysis.

Authors:  Joseph A Ladapo; Saul Blecker; Michael O'Donnell; Saahil A Jumkhawala; Pamela S Douglas
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 4.  Echocardiography, an Indispensable Tool for the Management of Diabetics, with or without Coronary Artery Disease, in Clinical Practice.

Authors:  Konstantinos Katogiannis; Dimitrios Vlastos; Foteini Kousathana; John Thymis; Aikaterini Kountouri; Emmanouil Korakas; Panagiotis Plotas; Konstantinos Papadopoulos; Ignatios Ikonomidis; Vaia Lambadiari
Journal:  Medicina (Kaunas)       Date:  2020-12-18       Impact factor: 2.430

5.  The safety, efficacy and cost-effectiveness of stress echocardiography in patients with high pretest probability of coronary artery disease.

Authors:  Alexandros Papachristidis; Daniela Cassar Demarco; Damian Roper; Ioannis Tsironis; Michael Papitsas; Jonathan Byrne; Khaled Alfakih; Mark J Monaghan
Journal:  Open Heart       Date:  2017-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.